Hematologic changes associated with zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda

Journal of the International Association of Physicians in AIDS Care

Volumn 8, Issue 2, 2009, Pages 128-138

  Forna, Fatu ^a   Moore, David ^b,c,d   Mermin, Jonathan ^a,b   Brooks, John T ^a   Were, Willy ^b   Buchacz, Kate ^a   Campbell, James D ^a,b   Downing, Robert ^b   Borkowf, Craig B ^a   Weidle, Paul J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Africa; antiretroviral therapy; rural; toxicity; Uganda; zidovudine

Indexed keywords

STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD EXAMINATION; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; FEMALE; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; MIDDLE AGED; RURAL POPULATION; UGANDA; VIROLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMATOLOGIC DISEASES; HEMATOLOGIC TESTS; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RURAL POPULATION; STAVUDINE; UGANDA; ZIDOVUDINE;

EID: 66149192678     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109709333081     Document Type: Article

References (22)

1. Sullivan P., Hanson DL, Chu SY, Jones JL, Ward JW Epidemiology of anemia in human immunodeficiency virus-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998 ; 91: 301-308. (Pubitemid 28018758)
2. Jaresko GS Etiology of neutropenia in HIV-infected patients. Am J Health Syst Pharm. 1999 ; 56: S5 - S8.
3. Moore RD, Forney D. Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 ; 29: 54-57. (Pubitemid 34094307)
4. Murphy MF, Metcalfe P., Waters AH, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol. 1987 ; 66: 337-340. (Pubitemid 17095293)
5. Richman DD, Fischl MA, Grieco MH, et al. The toxicityof azidothymidine in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1987 ; 317: 192-197.
6. Lugada ES, Mermin J., Kaharuza F., et al. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol. 2004 ; 11: 29-34. (Pubitemid 38090648)
7. Badenhorst CJ, Fourie J., Steyn K., et al. The haematological profile of urban black Africans aged 15-64 years in the cape peninsula. E Afr Med J. 2005 ; 72: 19-24.
8. Crawley J. Reducing the burden of anemia in infants and young children in malaria-endemic countries of Africa: from evidence to action. Am J Trop Med Hyg. 2004 ; 71: S25 - S34.
9. World Health Organization. Iron deficiency anemia: Assessment, prevention, and control. A guide for programme managers. Available at: http://www.who.int/nutrition/publications/en/ida-assessment-prevention-control. pdf. Accessed August 8, 2006.
10. Brabin BJ, Prinsen-Geerligs PD, Verhoeff FH, et al. Haematological profiles of the people of rural southern Malawi: an overview. Ann Trop Med Parasitol. 2004 ; 98: 71-83. (Pubitemid 38210468)
11. Geerligs PP, Brabin B., Mkumbwa A., Broadhead R., Cuevas LE The effect on haemoglobin of the use of iron cooking pots in rural Malawian households in an area with high malaria prevalence: a randomized trial. Trop Med Int Health. 2003 ; 8: 310-315. (Pubitemid 36513195)
12. Forna F., Liechty CA, Solberg P., et al. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr. 2007 ; 44: 456-462. (Pubitemid 46555382)
13. Moh R., Danel C., Sorho S., et al. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire. Antivir Ther. 2005 ; 10: 615-624. (Pubitemid 41224953)
14. Weidle PJ, Wamai N., Solberg P., et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet. 2006 ; 368: 1587-1594. (Pubitemid 44767594)
15. Regulatory Compliance Center. Division of AIDS (DAIDS) Table of Grading Severity of Adult Adverse Experiences. Bethesda, MD: National Institute of Allergy and Infectious Diseases ; 1992. Available at: http://rcc.tech-res-intl. com/tox-tables.htm. Accessed March 1, 2006.
16. Toure S., Gabillard D., Inwoley A., Seyler C., Gourvellec G., Anglaret X. Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6-year cohort study in Abidjan, Cote d'Ivoire. Trans R Soc Trop Med Hyg. 2006 ; 100: 785-790. (Pubitemid 43863178)
17. Mayr FB, Spiel AO, Leitner JM, Firbas C., Kliegel T., Jilma B. Ethnic differences in plasma levels of interleukin-8 and granulocyte colony stimulating factor (G-CSF). Transl Res. 2007 ; 149: 10-14. (Pubitemid 44969646)
18. Reed WW, Diehl LF Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med. 1992 ; 151: 501-505.
19. Kourtis AP, Bramson B., van der Horst C., et al. Low absolute neutrophil counts in African infants. J Int Assoc Physicians AIDS Care. 2005 ; 4: 73-76.
20. Wells J., Shetty AK, Stranix L., et al. Range of normal neutrophil counts in healthy Zimbabwean Infants: Implications for monitoring antiretroviral drug toxicity. J Acquir Immune Defic Syndr. 2006 ; 42: 460-463. (Pubitemid 44050894)
21. Moore D., Yiannoutsos C., Musick B., et al. Determinants of mortality among HIV-infected individuals receiving home-based ART in rural Uganda. 14th Conference on Retroviruses and Opportunistic Infections, Abstract 34, February 2007 ; Los Angeles, CA.
22. Mermin J., Ekwaru JP, Liechty CA, et al. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet. 2006 ; 367: 1256-1261.